Navigation Links
BeeCeuticals Organics Introduces First Dual Certified Body Care Product and Eco-Friendly Packaging Made from Corn
Date:9/27/2007

Bee-yond Body Balm Both USDA Organic & Fair Trade Certified(TM)

FORT LAUDERDALE, Fla., Sept. 27 /PRNewswire/ -- BeeCeuticals Organics, a company dedicated to providing body care products that enhance the health and well-being of their customers, community and the planet has launched an innovative and earth friendly way to package their Hive Five(TM) Kits. The new case, which contains five travel size products, is made entirely from 100% U.S. grown corn, not foreign petroleum. This material is produced from plastic that consists of polylactide, a corn-based versatile polymer.

"As ex-organic farmers in Maine, this package offers us an opportunity to support fellow U.S. farmers while offering our customers a beautiful package that is good for the environment," says Richie Gerber, President of BeeCeuticals Organics. "Many companies, including natural and organic ones, use vinyl bags for their kits even though it is one of the most toxic materials to produce. We wanted to move away from that, and believe we have found the most environmentally-friendly alternative with corn plastic."

Corn plastic is more energy efficient than other plastics and takes 60% less fossil fuel to produce. It also comes from yearly renewable resources, is recyclable, and industrially compostable and biodegradable. To view the new packaging, go to http://www.beeceuticals.com/store/press/balm_kit.jpg.

BeeCeuticals Organics is currently one of only two body care brands to be Fair Trade Certified(TM) by TransFair USA, the only third-party certifier of Fair Trade products in the United States. Fair trade guarantees livable wages for the workers and families of ingredient producers to improve opportunities for healthcare, housing and education.

All the items in the kit have a high percentage of certified organic ingredients and also contain their proprietary Organic Holistic Honey B
'/>"/>

SOURCE BeeCeuticals Organics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. TI Cycles Introduces Foldman
3. Canada Introduces Mandatory Nutrition Labeling
4. Amgen introduces Autoinjector For Treating Anemia
5. Cuba Introduces New Device for Detecting Vascular Diseases
6. China Introduces Solar-powered Baths
7. Allergan Introduces ‘Dermal Filler’ for Smile Lins
8. UAE Introduces Cervical Cancer Vaccine
9. Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation
10. Iceland Introduces Smoking Ban in Bars and Restaurants
11. Indian Introduces Paan-flavoured Condoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...has got the approval of US Food and Drug Administr...ation (ANDA) for Meloxicam tablets used in the tre... // The approval is for Meloxicam tablets of stre... the company informed the Bombay Stock Exchange. "...
... injection users in US and South Africa practice u...g to a new study. // "Forty percent of the HIV-pos...risk male partners, and more than half of the time... said lead author Dr. Mary H. Latka. The study is ...
...children are to be weighed, measured and interview...ned to tackle //the growing menace of childhood ob...about 25 percent of the children aged between 7 an... This problem is increasing the incidence of heart...
...ation confirmed the 42nd human bird flu death in I... the two worst-hit by the virus,//a senior officia...day. "The result was positive, we received from t... today," Hariadi Wibisono, the director at the min...
Other Medicine News:
(Date:8/26/2008)...IANAPOLIS, Aug. 26 /- Semafore Pharma...national Congress on Targeted Therapies,in Cancer ...ovel,multi-targeted kinase inhibitors that demonst...l studies., A novel and proprietary molecular sca...ing allowing for the design of pan-PI3 kinase inhi...
(Date:8/26/2008)...T WORTH, Texas, Aug. 26 /- Healthpoin... trial to evaluate the effectiveness of a,widely p...aneous wounds and,resulting scars. The pilot study... reduced incidence of hypertrophic scars and benef...se SANTYL(R) Ointment.(1,2), "Given the findings ...
(Date:8/26/2008)...LO PARK, Calif., Aug. 26 /-... the positive one-year follow-up data,from the CUS...e of the,peer-reviewed journal, EuroIntervention. ...tella, M.D., of University Medical Center Utrecht,...II Investigators from 13 clinical,sites across Eur...
(Date:8/26/2008)...TTLE, Aug. 26 /- Omeros Corporation t... a Phase 1/Phase 2 trial investigating,OMS103HP in...onstruction,surgery. OMS103HP is an investigationa...ation solution and is designed to improve postoper...ve pain and allow patients an,earlier return to wo...
Breaking Medicine Technology:Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2New technology enhances therapeutic potential of cord blood stem cells 3551 1New technology enhances therapeutic potential of cord blood stem cells 3551 2DURECT Corporation to Participate in Upcoming Healthcare Conferences 5853 1Walking Golf Course Affects Swing Performance 21249 1Walking Golf Course Affects Swing Performance 21249 2US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 1US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 2US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 3US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 4US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 5
...he Intramuscular Formulation,of Peramivir Supports...za, BIRMINGHAM, Ala., June 18, 2007 /PRNewswire-Fi...ed results from two Phase I,clinical studies of an...the Options for the Control of Influenza Conferenc...ional influenza,conference is held only once every...
...PRNewswire-FirstCall/ --,Genaera Corporation today...quemine (MSI-1436), its novel anti-obesity compoun...67th Scientific,Sessions, June 22 to 25 in Chicago...ine is a Multiple,Pathway Inhibitor that Causes Di...roves Plasma Insulin and Leptin Levels." , The pos...
Other Medicine Technology:BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 2BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 3BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 4BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 5BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 6Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4
IOL choppers for positioning intraocular lenses. Blunt tip avoids damage to intraocular lenses. Formed 10mm from tip. For .20mm diameter holes and larger.
J Cortex Extrator - Angled Right
Cortex Extractor - Charleux
Bimanual Aspiration Cannula
Medicine Products: